MedWatch

GN purchase story is very speculative, says analyst

Competition rules could block a purchase of GN Store Nord and subsequent divestment of GN Hearing, says a Sydbank analyst on the speculative story that this might be underway.

Photo: GN Store Nord / PR

Although GN Store Nord is reasonably priced, it wouldn’t exactly be easy pickings for one or several players to buy up the entire group, assesses Søren Løntoft Hansen, a senior equity analyst at Sydbank.

Løntoft Hansen is commenting on a recent story by Inside Business, which reported that a number of international private equity firms and industrial players were looking into buying GN Store Nord stock after a recent price drop.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs